Swift Run Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$194K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$6.75M |
| 2 |
Huntsman Corp
HUN
|
+$2.63M |
| 3 |
Marathon Petroleum
MPC
|
+$2.63M |
| 4 |
Comcast
CMCSA
|
+$2.01M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$1.97M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 26.28% |
| 2 | Financials | 21% |
| 3 | Energy | 16.52% |
| 4 | Materials | 12.51% |
| 5 | Real Estate | 6.95% |
Similar funds
Swift Run Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Swift Run Capital Management held 39 positions worth $76.3M, down 29% from $107M the previous quarter. Its ten largest holdings account for 77% of the portfolio.
Swift Run Capital Management withdrew a net $31.3M in Q4 2019, closing 6 positions and reducing 20 holdings. Its most notable exit was Goldman Sachs, an estimated $6.75M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 26% of assets, up from 22% a quarter earlier, followed by Financials and Energy.
Against the trend, Swift Run Capital Management opened a new position in Pfizer worth $202K.
- Swift Run Capital Management's largest Q4 2019 buy was Pfizer: 5,433 shares worth $202K.
- Swift Run Capital Management's biggest Q4 2019 reduction was Huntsman Corp, cutting an estimated $2.63M.
- Swift Run Capital Management fully exited Goldman Sachs in Q4 2019, selling an estimated $6.75M.
- Swift Run Capital Management's ten largest holdings make up 77% of its $76.3M portfolio in Q4 2019.
- Swift Run Capital Management opened 1 new position and closed 6 in Q4 2019.
- Swift Run Capital Management's portfolio value fell 29% quarter-over-quarter to $76.3M.
Based on Swift Run Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.